127 related articles for article (PubMed ID: 14662705)
1. Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice.
Zacharia LC; Gogos JA; Karayiorgou M; Jackson EK; Gillespie DG; Barchiesi F; Dubey RK
Circulation; 2003 Dec; 108(24):2974-8. PubMed ID: 14662705
[TBL] [Abstract][Full Text] [Related]
2. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs.
Dubey RK; Gillespie DG; Zacharia LC; Barchiesi F; Imthurn B; Jackson EK
Hypertension; 2003 Mar; 41(3 Pt 2):807-13. PubMed ID: 12624000
[TBL] [Abstract][Full Text] [Related]
3. Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs.
Barchiesi F; Jackson EK; Gillespie DG; Zacharia LC; Fingerle J; Dubey RK
Hypertension; 2002 Apr; 39(4):874-9. PubMed ID: 11967242
[TBL] [Abstract][Full Text] [Related]
4. Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast.
Dubey RK; Jackson EK; Gillespie DG; Rosselli M; Barchiesi F; Krust A; Keller H; Zacharia LC; Imthurn B
J Clin Endocrinol Metab; 2005 Jan; 90(1):247-55. PubMed ID: 15507517
[TBL] [Abstract][Full Text] [Related]
5. Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth.
Dubey RK; Gillespie DG; Zacharia LC; Rosselli M; Imthurn B; Jackson EK
Hypertension; 2002 Feb; 39(2 Pt 2):412-7. PubMed ID: 11882582
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines block the antimitogenic effect of estradiol on human coronary artery smooth muscle cells.
Dubey RK; Jackson EK; Gillespie DG; Zacharia LC; Imthurn B
J Clin Endocrinol Metab; 2004 Aug; 89(8):3922-31. PubMed ID: 15292328
[TBL] [Abstract][Full Text] [Related]
7. Catecholamines block the antimitogenic effect of estradiol on human glomerular mesangial cells.
Dubey RK; Zacharia LC; Gillespie DG; Imthurn B; Jackson EK
Hypertension; 2003 Sep; 42(3):349-55. PubMed ID: 12913061
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells.
Zacharia LC; Jackson EK; Gillespie DG; Dubey RK
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1745-50. PubMed ID: 11701460
[TBL] [Abstract][Full Text] [Related]
9. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms.
Dubey RK; Gillespie DG; Zacharia LC; Rosselli M; Korzekwa KR; Fingerle J; Jackson EK
Biochem Biophys Res Commun; 2000 Nov; 278(1):27-33. PubMed ID: 11071850
[TBL] [Abstract][Full Text] [Related]
10. Medroxyprogesterone abrogates the inhibitory effects of estradiol on vascular smooth muscle cells by preventing estradiol metabolism.
Dubey RK; Jackson EK; Gillespie DG; Zacharia LC; Wunder D; Imthurn B; Rosselli M
Hypertension; 2008 Apr; 51(4):1197-202. PubMed ID: 18259021
[TBL] [Abstract][Full Text] [Related]
11. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
12. Catechol-o-methyltransferase and methoxyestradiols participate in the intraoviductal nongenomic pathway through which estradiol accelerates egg transport in cycling rats.
Parada-Bustamante A; Orihuela PA; Ríos M; Navarrete-Gómez PA; Cuevas CA; Velasquez LA; Villalón MJ; Croxatto HB
Biol Reprod; 2007 Dec; 77(6):934-41. PubMed ID: 17699737
[TBL] [Abstract][Full Text] [Related]
13. Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells.
Dubey RK; Gillespie DG; Keller PJ; Imthurn B; Zacharia LC; Jackson EK
Hypertension; 2002 Feb; 39(2 Pt 2):418-24. PubMed ID: 11882583
[TBL] [Abstract][Full Text] [Related]
14. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome.
Salih SM; Jamaluddin M; Salama SA; Fadl AA; Nagamani M; Al-Hendy A
Fertil Steril; 2008 May; 89(5 Suppl):1414-21. PubMed ID: 17612537
[TBL] [Abstract][Full Text] [Related]
15. Catecholamines block 2-hydroxyestradiol-induced antimitogenesis in mesangial cells.
Zacharia LC; Jackson EK; Gillespie DG; Dubey RK
Hypertension; 2002 Apr; 39(4):854-9. PubMed ID: 11967239
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
[TBL] [Abstract][Full Text] [Related]
17. Migration and growth are attenuated in vascular smooth muscle cells with type VIII collagen-null alleles.
Adiguzel E; Hou G; Mulholland D; Hopfer U; Fukai N; Olsen B; Bendeck M
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):56-61. PubMed ID: 16269661
[TBL] [Abstract][Full Text] [Related]
18. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
[TBL] [Abstract][Full Text] [Related]
19. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
Ashburn SP; Han X; Liehr JG
Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase is dispensable for vascular protection by estradiol in mouse models of atherosclerosis and neointima formation.
Wilhelmson AS; Bourghardt-Fagman J; Gogos JA; Fogelstrand P; Tivesten A
Endocrinology; 2011 Dec; 152(12):4683-90. PubMed ID: 22009725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
